Subclavian artery stenting: Immediate and mid term clinical follow-up results.
BACKGROUND: Intravascular stents are increasingly being used to treat subclavian artery obstructive disease. This study aimed to assess the immediate and mid-term clinical outcome of subclavian artery stenting. METHODS AND RESULTS: Total occlusion of the subclavian artery was seen in 7 (28%) out of the 25 consecutive patients treated for subclavican artery stenosis. Mean lesion length was 14 +/- 4.3 mm. The mean preprocedure diameter stenosis was reduced from 83.2 +/- 14.9% to 9.6 +/- 5.4% postprocedure. Procedural success was achieved in all patients. Clinical follow-up was obtained in all patients. The initial success was maintained at follow-up (mean = 12 +/- 4 months) in 24 (96%) patients. Recurrence of symptoms occurred in 1 (4%) patient who had an angiographically documented restenosis four months after the procedure. It was successfully redilated. CONCLUSION: Stenting for subclavian artery obstructive disease is safe, technically feasible and has favorable clinical outcomes. It may be considered as the therapy of choice for subclavian artery obstructive disease.
Sheiban
Imad
I
Division of Cardiology, Interventional Cardiology Laboratory, University of Torino, Torino, Italy.
Dharmadhikari
Aniruddha
A
Melissano
Germano
G
Tzifos
Vaios
V
Montorfano
Matteo
M
Leonardo
Filippo
F
Di Mario
Carlo
C
Chiesa
Roberto
R
Colombo
Antonio
A